Comparative clinical study on microwave ablation combined with cisplatin plus gemcitabine or pemetrexed in treatment of advanced NSCLC

ConclusionThe two therapeutic regimens have similar efficacy in treatment of advanced NSCLC, but MPC causes slighter myelosuppression and can be the first ‐line therapy for advanced NSCLC.

Source: The Clinical Respiratory Journal - May 21, 2020 Category: Respiratory Medicine Authors: YingQing Zhang, Yan Feng, YongLei Wu, YingXin Zhou, LinLan Wang Tags: ORIGINAL ARTICLE Source Type: research